Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

Autor: Amani-Bosse Clarisse, Tanon Aristophane K, Tonwe-Gold Besigin, Coffie Patrick A, Bédikou Gédéon, Abrams Elaine J, Dabis François, Ekouevi Didier K

Publikováno v: BMC Infectious Diseases, Vol 10, Iss 1, p 188 (2010)

Abstract Background In resource-limited settings where nevirapine-containing regimen is the preferred regimen in women, data on severe adverse events (SAEs) according to CD4 cell count are limited. We estimated the incidence of SAEs according to CD4

Externí odkaz: https://doaj.org/article/9bef0c70d7ad43edac9a28fa2c606efa

Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d’Ivoire. The Pedi-Test DBS ANRS 12183 Study

Autor: Yapo, Vincent, Toni, Thomas d’Aquin, Desmonde, Sophie, Amani-Bosse, Clarisse, Oga, Maxime, Lenaud, Severin, Menan, Hervé, Timité-Konan, Marguerite, Leroy, Valériane, Rouzioux, Christine

Publikováno v: In Journal of Virological Methods November 2013 193(2):439-445

Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.

Autor: Amani-Bosse, Clarisse¹, Dahourou, Désiré Lucien^2,3,4, Malateste, Karen⁴, Amorissani-Folquet, Madeleine⁵, Coulibaly, Malik², Dattez, Sophie⁴, Emieme, Arlette⁶, Barry, Mamadou⁷, Rouzioux, Christine⁸, N'gbeche, Sylvie⁹, Yonaba, Caroline¹⁰, Timité-Konan, Marguerite¹¹, Mea, Véronique¹, Ouédraogo, Sylvie¹², Blanche, Stéphane^13,14, Meda, Nicolas^2,3,15, Seguin-Devaux, Carole¹⁶, Leroy, Valériane¹⁷ Valeriane.Leroy@inserm.fr

Publikováno v: Journal of the International AIDS Society. 4/25/2017, Vol. 20, p1-13. 13p. 1 Diagram, 6 Charts.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children

Autor: Desmonde, Sophie, Dicko, Fatoumata, Koueta, Fla, Eboua, Tanoh, Balestre, Eric, Amani-Bosse, Clarisse, Aka, Edmond A, Lawson-Evi, Koko, Amorissani-Folquet, Madeleine, Kouakou, Kouadio, Koumakpai, Siriatou, Renner, Lorna, Signaté Sy, Haby, Leroy, Valériane, Sodemann, Morten

Publikováno v: AIDS
AIDS, Lippincott, Williams & Wilkins, 2014, 28 (11), pp.1645-55. ⟨10.1097/QAD.0000000000000272⟩
Desmonde, S, Dicko, F, Koueta, F, Eboua, T, Balestre, E, Amani-Bosse, C, Aka, E A, Lawson-Evi, K, Amorissani-Folquet, M, Kouakou, K, Koumakpai, S, Renner, L, Signaté Sy, H, Leroy, V & IeDEA West Africa Paediatric Collaboration (Christian Erikstrup, Alex Laursen, Christian Wejse, Lars Østergaard; members) 2014, ' Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children ', AIDS, vol. 28, no. 11, pp. 1645-55 . https://doi.org/10.1097/QAD.0000000000000272
Desmonde, S, Dicko, F, Koueta, F, Eboua, T, Balestre, E, Amani-Bosse, C, Aka, E A, Lawson-Evi, K, Amorissani-Folquet, M, Kouakou, K, Koumakpai, S, Renner, L, Signaté Sy, H, Leroy, V, IeDEA West Africa Paediatric Collaboration & Sodemann, M 2014, ' Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children ', AIDS, vol. 28, no. 11, pp. 1645-1655 . https://doi.org/10.1097/QAD.0000000000000272

OBJECTIVE: We describe the association between age at antiretroviral therapy (ART) initiation and 24-month CD4 cell response in West African HIV-infected children.METHODS: All HIV-infected children from the IeDEA paediatric West African cohort, initi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac6a54313e4f683e285908aba36ad6fc
https://hal.inria.fr/hal-01108205